-
May 2010: New Safety Information For Xenical And Alli Regarding Cases Of Severe Liver Injury
FDA Had Been Investigating Reports Of Hepatotoxicity Involving Their Active Ingredient, Orlistat, For Past Year (Posted by Tom Lamb at DrugInjuryWatch.com)______________________________________________________________________________ UPDATE: EMA Decides Orlistat Benefits Worth the Risks The CHMP finalized its review…
-
Zithromax-Induced Liver Injury Case Report Where There Was No History Of Liver Problems
Drug-Induced Liver Injury (DILI), Or Toxicity, Can Cause Both Acute And Chronic Liver Disease (Posted by Tom Lamb at DrugInjuryWatch.com) To get our bearings, we start with some points taken from the Abstract for the…
-
Serevent, Advair, and Foradil: Despite The Increased Risk of Severe Asthma Episodes and Death, Monotherapy Use Continues
Numerous Safety Warnings From FDA About These LABA Asthma Drugs Have Seemingly Been Ignored By Patients, According To New Medco Study (Posted by Tom Lamb at DrugInjuryWatch.com) As some of you may recall, back…
-
April 2010: Senator Chuck Grassley Wants More Independence And Power For FDA Drug-Safety Reviewers
This Idea Has Been Circulating Since The 2005 Grassley-Dodd Bill, With No Real Movement Forward In Past Five Years (Posted by Tom Lamb at DrugInjuryWatch.com) Five years ago, on April 28, 2005, in the…
-
Is Bayer Warning Or Attacking With Its New YAZ / Yasmin Package Insert, Or Label, In The U.S.
Bayer Says YAZ / Yasmin Safety Profile Is Comparable To Older Birth Control Pills, But European Regulators See Possible Increased Risk Of Blood Clot Side Effects (Posted by Tom Lamb at DrugInjuryWatch.com) _________________________________________________________________________________________ UPDATE: "Bayer…